GH Q3 2025 Earnings — Guardant Health, Inc. Revenue & Financial Results | Market Cap Arena

GHGuardant Health, Inc.

$12B

Q3 2025 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$265M+38.5% YoY

Gross Profit

$172M64.7% margin

Operating Income

-$99M-37.3% margin

Net Income

-$93M-35.0% margin

EPS (Diluted)

$-0.74

QoQ Revenue Growth

+14.3%

Cash Flow

Operating Cash Flow

-$35M

Free Cash Flow

-$46M

Stock-Based Comp.

$43M

Balance Sheet

Total Assets

$1.3B

Total Liabilities

$1.6B

Stockholders' Equity

-$354M

Cash & Equivalents

$580M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$265M	$191M	+38.5%
Gross Profit	$172M	$117M	+46.7%
Operating Income	-$99M	-$117M	+15.6%
Net Income	-$93M	-$108M	+13.9%

Revenue Segments

Oncology

$184M70%

Biopharma & Data

$55M21%

Screening

$24M9%

Licensing & Other

$2M1%

Geographic Segments

UNITED STATES

$249M94%

Non-US

$16M6%